|
Showing 1 - 6 of
6 matches in All Departments
Hepatitis C and Dengue viruses belong to the family of
Flaviviridae. Viruses in this family are enveloped, have
positive-sense RNA and are responsible for a variety of life
threatening diseases. Hepatitis C virus is the major etiological
agent of post-transfusion hepatitis worldwide. An estimated 3 % of
the world's population is infected with HCV according to the World
Health Organization. Infection with HCV will most regularly result
in chronic hepatitis, which leads to liver cirrhosis,
hepatocellular carcinoma and liver failure. Dengue is currently the
most important viral disease transmitted by mosquitoes afflicting
humans the world context. Clinical symptoms range from mild fevers
to a severe haemorrhagic disease. To date neither specific
antiviral treatments exist nor are there any vaccines available for
both infections. Thus there is an urgent need for new therapies.
More than 170 million people worldwide are currently chronically
infected with the Hepatitis C virus. Similarly, Dengue fever
infects 50 million per year in central Africa. It is the same story
for so many other viruses that are members of the flaviviridae
family. Disproportionally to the severity of an infection with
almost all members of Flaviviridae, no specific antiviral therapy
is available today. There are drugs neither for the treatment nor
for the prevention upon infection. Scientists have isolated various
proteins and extensively study some of them in an attempt to get
information that will eventually be combined to a strategy against
the viruses. Herein, an effort is made to describe the current
status of antiviral research within flaviviridae, homology
modelling and structure based drug design techniques that may soon
lead to new generation of stratagems against flaviviridae. Finally,
insights into novel technologies in drug design technology are
provided.
The Flaviviridae family of viruses, description, properties and
complete genome bank of all family members
A brief introduction to the basic knowledge underlying modern
molecular modelling
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.